I am delighted to announce the publication of my latest research:
“A Multi-Country Evidence Synthesis on Somalis’ Cross-Border Healthcare: An Epidemiological Analysis of Drivers, Costs, and Systemic Implications (2014–2026)”
The article examines Somali cross-border healthcare seeking between 2014 and 2026 and argues that this phenomenon should not be viewed simply as “medical tourism,” but rather as a structural response to weaknesses within Somalia’s health system, especially gaps in tertiary care, diagnostics, continuity of care, and financial protection. It synthesizes evidence on Somali patients seeking treatment in India, Turkey, Ethiopia, and Egypt, using a PRISMA-informed rapid evidence synthesis approach.
In substance, the paper shows that Somali patients travel abroad mainly because key services are unavailable or unreliable at home. The most important clinical drivers include cancer care, cardiovascular disease, renal disease and transplantation, orthopedic surgery, fertility treatment, and some complex infectious diseases. India appears as the most strongly measured corridor for high-acuity tertiary care; Turkey is notable for surgery, fertility care, and some specialty services; Ethiopia serves as a regional access route for urgent and intermediate care; and Egypt is an important nearby destination for cardiology and oncology, though with weaker public data.
The article is highly significant for the Somali community because it frames overseas treatment as a symptom of national health-system fragility. It highlights how families are pushed into severe financial hardship through out-of-pocket spending, remittances, savings depletion, community fundraising, and even asset liquidation. The paper also stresses that the burden is not only clinical but economic and social, with treatment abroad causing capital leakage from Somalia and weakening the long-term development of domestic health infrastructure.
For healthcare professionals, the article is important because it identifies the main service gaps that force patients abroad and shows where continuity of care breaks down, including delayed diagnosis, documentation problems, financing interruptions, broker dependence, and weak post-return follow-up. For policymakers, it provides evidence that cross-border care is now functioning like an informal parallel tertiary-care system and requires stronger governance, financial protection, and domestic investment. For academics, the paper is valuable because it organizes scattered evidence into a structured analytical framework while also clarifying major evidence gaps, especially the absence of a national outbound referral registry and weak longitudinal outcome data.
Among the main findings, the paper reports that India is the only destination with a relatively robust public Somali-specific series, including 3,072 Somali medical-purpose arrivals in 2015, 5,549 in 2016, 4,964 in 2017, 3,454 in 2019, 1,386 in 2020, 4,162 in 2021, 10,206 in 2022, 16,411 in 2023, and 12,261 in 2024, with a clear post-pandemic surge. It also estimates a mean direct household cost of about US$8,543 per outbound treatment episode and a central 2024 four-corridor spending scenario of roughly US$219.3 million. The conclusion further notes that annual capital outflows linked to outbound medical mobility exceed US$100 million.
The article recommends several actions. It calls for creation of a National Cross-Border Care and Referral Program with standardized documentation, clinical triage rules, and compulsory discharge handover. It recommends establishing a national outbound referral registry to track diagnoses, destinations, financing, and outcomes over time. It also calls for stronger financial protection for catastrophic illness, regulation of brokers and facilitators, bilateral agreements with destination countries, and targeted domestic investment in high-leakage services such as oncology diagnostics, chemotherapy day care, dialysis quality networks, advanced imaging, pathology, and selected cardiac services.
Overall, the article’s central message is that Somali cross-border healthcare is a powerful warning signal about the state of the national health system. Its most important contribution is showing that reducing unnecessary medical travel will require not only better referral governance, but also sustained investment in domestic tertiary-care capacity, financial risk protection, and stronger health-system stewardship.